"Medical Practice dedicated to Brain Health and Memory Care. We provide Concierge Medical Services in addition to our worldwide clinical research related to helping find cures for neurological diseases such as Alzheimer's and other Dementias."

During the past decade, Kerwin Medical Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kerwin Medical Center" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Washington University School of Medicine" with 2 trials sponsored and "Acumen Pharmaceuticals" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kerwin Medical Center" #1 collaborator was "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 2 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator and "Avid Radiopharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Kerwin Medical Center" are "Alzheimer Disease" (9 trials), "Alzheimer's Disease" (3 trials), "Alzheimers Disease" (3 trials), "Alzheimers Disease, Familial" (2 trials) and "Dementia" (2 trials). Many other conditions were trialed in "Kerwin Medical Center" in a lesser frequency.

Most popular intervention types in "Kerwin Medical Center" are "Drug" (17 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Gantenerumab" (4 trials), "Lecanemab" (3 trials), "Crenezumab" (2 trials) and "Donanemab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kerwin Medical Center" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Kerwin Medical Center". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kerwin Medical Center, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Kerwin Medical Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".